Raytheon Technologies Corp vs 22nd Century Group Inc — how do they compare? Raytheon Technologies Corp trades at $223.64 (market cap $301.71B), while 22nd Century Group Inc trades at $4.4 (market cap $1.52M). The key difference: Raytheon Technologies Corp is far larger — about 198493.4× 22nd Century Group Inc's market cap, and Raytheon Technologies Corp pays a 1.3% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| RTX | XXII | |
|---|---|---|
Market Cap | $301.71B | $1.52M |
Sector | Industrials | Technology |
52-Week High | $224.12 | $801.00 |
52-Week Low | $151.75 | $3.72 |
Enterprise Value | $332.26B | -$6.71M |
Dividend Yield | 1.3% | — |
Signals from Pluang's Aura AI — not financial advice
RTX trades at $224.12, up 0.49% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages and support at $223. Fundamentally, revenue grew to $88.6B in 2025 with net income of $6.73B, and recent contract wins like the $515M SPY-6 radar award bolster growth prospects. Earnings have consistently beaten estimates, with Q2 2026 EPS of $1.89 exceeding expectations.
The outlook is positive given robust defense spending and operational execution, but valuation multiples like a P/E of 39.41 pose risks if growth slows. Analyst consensus is bullish with a $233.14 price target, though overbought RSI levels suggest near-term consolidation may occur. Key risks include execution delays and macroeconomic pressures on defense budgets.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →